LXEO
Price
$4.43
Change
-$0.21 (-4.53%)
Updated
May 5, 04:59 PM (EDT)
Capitalization
154.03M
3 days until earnings call
VERV
Price
$5.14
Change
-$0.05 (-0.96%)
Updated
May 5, 04:59 PM (EDT)
Capitalization
462.65M
2 days until earnings call
Ad is loading...

LXEO vs VERV

Header iconLXEO vs VERV Comparison
Open Charts LXEO vs VERVBanner chart's image
Lexeo Therapeutics
Price$4.43
Change-$0.21 (-4.53%)
Volume$3.74K
Capitalization154.03M
Verve Therapeutics
Price$5.14
Change-$0.05 (-0.96%)
Volume$22.3K
Capitalization462.65M
LXEO vs VERV Comparison Chart
Loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. VERV commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a StrongBuy and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (LXEO: $4.64 vs. VERV: $5.19)
Brand notoriety: LXEO and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 128% vs. VERV: 91%
Market capitalization -- LXEO: $154.03M vs. VERV: $462.65M
LXEO [@Biotechnology] is valued at $154.03M. VERV’s [@Biotechnology] market capitalization is $462.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 6 bullish TA indicator(s).

  • LXEO’s TA Score: 6 bullish, 4 bearish.
  • VERV’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than VERV.

Price Growth

LXEO (@Biotechnology) experienced а +26.09% price change this week, while VERV (@Biotechnology) price change was -9.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.58%. For the same industry, the average monthly price growth was +18.86%, and the average quarterly price growth was -6.53%.

Reported Earning Dates

LXEO is expected to report earnings on May 08, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($463M) has a higher market cap than LXEO($154M). VERV YTD gains are higher at: -7.979 vs. LXEO (-29.483). LXEO has higher annual earnings (EBITDA): -84.47M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. LXEO (157M). LXEO has less debt than VERV: LXEO (10.4M) vs VERV (70M). VERV has higher revenues than LXEO: VERV (32.3M) vs LXEO (0).
LXEOVERVLXEO / VERV
Capitalization154M463M33%
EBITDA-84.47M-221.91M38%
Gain YTD-29.483-7.979370%
P/E RatioN/AN/A-
Revenue032.3M-
Total Cash157M524M30%
Total Debt10.4M70M15%
TECHNICAL ANALYSIS
Technical Analysis
LXEOVERV
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 25 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCGX10.460.23
+2.25%
Mercer US Small/Mid Cap Equity Y3
BPTIX189.043.92
+2.12%
Baron Partners Institutional
CADVX18.390.28
+1.55%
Calamos Dividend Growth A
AUIZX31.300.42
+1.36%
AB Equity Income Z
EREMX14.840.19
+1.30%
Parametric Emerging Markets R6

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.49%
ARWR - LXEO
48%
Loosely correlated
N/A
RCKT - LXEO
47%
Loosely correlated
+1.91%
VERV - LXEO
39%
Loosely correlated
-5.64%
RGNX - LXEO
38%
Loosely correlated
+5.80%
PRME - LXEO
38%
Loosely correlated
-3.45%
More